FDA NDC Directory · JSON-LD · Markdown

TYENNE

NDC 65219-596 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameTocilizumab-aazg
Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryBiologic License Application · App BLA761449
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTOCILIZUMAB (162 mg/.9mL)
Marketing started20250901
Package count1

External sources

Source: openFDA. Public-domain (CC0).